CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | ROSSI DINO A Director | Sale | −341 | $325.60 | $111K | 74,659 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −2,287 | $326.60 | $747K | 72,372 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −5,226 | $327.39 | $1.7M | 67,146 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −1,687 | $328.52 | $554K | 65,459 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −7,428 | $329.60 | $2.4M | 58,031 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −4,896 | $330.36 | $1.6M | 53,135 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −3,095 | $331.43 | $1.0M | 50,040 |
| 2026-08-14 | ROSSI DINO A Director | Sale | −40 | $333.23 | $13K | 50,000 |
| 2026-06-25 | Thomas John Charles EVP, General Counsel | Option exercise 10b5-1 | +1,000 | $179.25 | $179K | 1,000 |
| 2026-06-25 | Thomas John Charles EVP, General Counsel | Sale 10b5-1 | −1,000 | $347.27 | $347K | 0 |
| 2026-06-25 | Thomas John Charles EVP, General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 6,500 | ||
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −320 | $300.75 | $96K | 1,402,835 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −593 | $302.25 | $179K | 1,402,242 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −247 | $303.17 | $75K | 1,401,995 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −400 | $304.89 | $122K | 1,401,595 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −480 | $305.87 | $147K | 1,401,115 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,348 | $307.09 | $414K | 1,399,767 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −12,729 | $307.81 | $3.9M | 1,387,038 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,803 | $308.89 | $1.2M | 1,383,235 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,801 | $309.95 | $868K | 1,380,434 |
Page 3 of 35 · 689 trades